Tyler Lefevre

Tyler Lefevre is a dynamic and motivated scientist currently serving as a Postdoctoral Fellow in Antibody Design & Engineering at AstraZeneca since 2023. With over five years of experience in biochemistry, biophysics, cell signaling, and molecular pharmacology, Tyler has developed expertise in protein design, expression, and functional analysis in various systems. Previously, Tyler earned a PhD in Chemical Biology from the University of Michigan - Rackham Graduate School, where research focused on Gα subtype specificity and protein-target interactions. Tyler's early career included a role at The Dow Chemical Company, where they conducted environmental studies and integrated automated systems into analytical protocols.